After assessing the clinical value of MALAT1 in breast cancer, a MALAT1–miRNA–mRNA regulatory network was constructed using a bioinformatics approach, which should facilitate further experimental studies and may be used to refine biomarker predictions for developing novel therapeutic approaches in breast cancer. Here, MALAT1 is linked to breast cancer.